tirzepatide versus retatrutide Semaglutide vs. vs. stacking tirzepatide and retatrutide Retatrutide

Some notice shifts in desire within weeks of starting treatment

Glucagon-like Peptide-1: new regulator in lipid metabolism

Extended Data Figure 3 Single-particle cryo-EM analysis of the hGLP-1rGLP-1RG s complex

By 2026, the landscape includes selective GLP-1 receptor agonists, dual GLP-1/GIP receptor co-agonists, triple receptor agonists targeting GLP-1/GIP/glucagon receptors simultaneously, and the first non-peptide oral small-molecule GLP-1 agonist

All very reassuring but the FDA required additional studies in animals and the establishment of a cancer registry to monitor the annual incidence of medullary thyroid cancer over the next 15 years

Studies examining body composition changes during GLP-1 therapy, including the STEP trials (semaglutide) and SURMOUNT-1 (tirzepatide), have demonstrated that approximately 2540% of total weight lost may come from lean body mass, including skeletal muscle, rather than exclusively from fat mass